Concepedia

Rhonda Griffin

RG

Statistics

Publications

6

Citations

225

H-Index

6

Active since

2013

Affiliations

Grifols (United States)(Current)

Grifols (Spain)

Research Triangle Park Foundation

Bioscience Research

Western University

Rhonda Griffin is an author at Grifols (United States) specializing in pharmacotherapy, pharmacology, and quantitative myasthenia gravis score.

Publications per year

2013–2024

6

Publications

6

Safety and Pharmacokinetics of 120 mg/kg versus 60 mg/kg Weekly Intravenous Infusions of Alpha-1 Proteinase Inhibitor in Alpha-1 Antitrypsin Deficiency: A Multicenter, Randomized, Double-Blind, Crossover Study (SPARK)

Michael Campos, Friedrich Kueppers, James Stocks et al. · COPD Journal of Chronic Obstructive Pulmonary Disease · 2013 · 62 citations · Full text

, , +13

Inhaled alpha 1 -proteinase inhibitor therapy in patients with cystic fibrosis

Amit Gaggar, Junliang Chen, James F. Chmiel et al. · Journal of Cystic Fibrosis · 2015 · 56 citations · Full text

, , +12

SPARTA clinical trial design: Exploring the efficacy and safety of two dose regimens of alpha1-proteinase inhibitor augmentation therapy in alpha1-antitrypsin deficiency

Susan C. Sorrells, Sandra Camprubí, Rhonda Griffin et al. · Respiratory Medicine · 2015 · 45 citations · Full text

, , +12

A Phase 3 Multicenter, Prospective, Open-Label Efficacy and Safety Study of Immune Globulin (Human) 10% Caprylate/Chromatography Purified in Patients with Myasthenia Gravis Exacerbations

Guntis Karelis, Rodica Bălașa, Jan De Bleecker et al. · European Neurology · 2019 · 28 citations · Full text

, , +14

Randomized Double-Blind Placebo-Controlled Trial of the Corticosteroid-Sparing Effects of Immunoglobulin in Myasthenia Gravis

Vera Bril, Andrzej Szczudlik, Antanas Vaitkus et al. · Neurology · 2022 · 23 citations · Full text

, , +17

1–5 of 6